Skip to content
  • Numero Verde: 800592068

  • Numero Verde: 800592068

Progetto FülopProgetto Fülop
  • Home
  • Chi siamo
    • Proteggiti e proteggi
    • Il progetto
    • Buone norme
  • Le ICA
  • Racconta la tua storia
  • Media
    • Testimonianze
    • News ed eventi
  • Contatti
  • Area riservata

ICA e ANTIBIOTICO-RESISTENZA

The antibiotic paradox: why companies can’t afford to create life-saving drugs

2020, ICA e ANTIBIOTICO-RESISTENZA

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the eu and the European Economic Area in 2015: a population-level modelling analysis

2019, ICA e ANTIBIOTICO-RESISTENZA

L’uso degli antibiotici in Italia – Rapporto Nazionale 2019 – scheda di sintesi

2019, ICA e ANTIBIOTICO-RESISTENZA

Piano Nazionale di Contrasto dell’Antimicrobico-Resistenza (PNCAR) 2017-2020, 2017

2017, ICA e ANTIBIOTICO-RESISTENZA

Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations

2014, ICA e ANTIBIOTICO-RESISTENZA

Antimicrobial resistance: global report on surveillance

2014, ICA e ANTIBIOTICO-RESISTENZA

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

2012, ICA e ANTIBIOTICO-RESISTENZA

New Drugs To Tackle Antimicrobial Resistance – Analysis Of Eu Policy Options

2011, ICA e ANTIBIOTICO-RESISTENZA

Attributable hospital cost and length of stay associated with health care associated infections caused by antibiotic-resistant Gram-negative bacteria

2010, ICA e ANTIBIOTICO-RESISTENZA

Policies and incentives for promoting innovation in antibiotic

2010, ICA e ANTIBIOTICO-RESISTENZA

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

2008, ICA e ANTIBIOTICO-RESISTENZA

Antimicrobial resistance: it’s not just for hospitals

2007, ICA e ANTIBIOTICO-RESISTENZA

The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?

2006, ICA e ANTIBIOTICO-RESISTENZA

Antibacterial drug discovery – then, now and the genomics future

2006, ICA e ANTIBIOTICO-RESISTENZA

The relationship between antimicrobial resistance and patient outcomes: mortality, length of stay, and health care costs

2006, ICA e ANTIBIOTICO-RESISTENZA

Evolution of the serine β-lactamases: past, present and future

2004, ICA e ANTIBIOTICO-RESISTENZA

Microbiology in the 21st century: where are we and where are we going?

2004, ICA e ANTIBIOTICO-RESISTENZA

Priority medicines for Europe and the world

2004, ICA e ANTIBIOTICO-RESISTENZA

Infectious Diseases: Considerations for the 21st Century

2001, ICA e ANTIBIOTICO-RESISTENZA

logo fulop footer
800592068
info@fulop.it
Privacy Policy Cookie Policy
Sitemap
  • Home
  • Chi siamo
    • Proteggiti e proteggi
    • Il progetto
    • Buone norme
  • Le ICA
  • Racconta la tua storia
  • Media
    • Testimonianze
    • News ed eventi
  • Contatti
Ultime dal blog
  • Intervento Avvocato Raffaele Di Monda al congresso Microbiology & Infections – Pescara 2022 Ottobre 26, 2022
  • Microbiology & Infections Pescara 2022 Ottobre 12, 2022
  • LA SALUTE È NELLE TUE MANI: Una giornata di formazione e informazione sull’importanza dell’igiene delle mani. Giugno 10, 2022
Iscriviti alla newsletter


    Accetto la privacy policy

    • Home
    • Chi siamo
      • Proteggiti e proteggi
      • Il progetto
      • Buone norme
    • Le ICA
    • Racconta la tua storia
    • Media
      • Testimonianze
      • News ed eventi
    • Contatti
    • Area riservata